CK Life Sciences Int'l., (Holdings) Inc. reported consolidated earnings statement for the year ended December 31, 2014. For the year, the company reported turnover of HKD 4,954,043,000 against HKD 4,970,927,000 a year ago. Profit before taxation was HKD 321,130,000 against HKD 303,729,000 a year ago. Profit for the year was HKD 272,752,000 against HKD 234,546,000 a year ago. Attributable to shareholders of the company was HKD 263,558,000 against HKD 229,008,000 a year ago. Basic and diluted earnings per share were 2.74 cents against 2.38 cents a year ago.

The Board of Directors has recommended a final dividend of HKD 0.008 per share for the year ended 31 December 2014 against HKD 0.007 per share in 2013, a 14% increase over the previous year. The proposed dividend will be paid on 2 June 2015 following approval at the 2015 Annual General Meeting to those shareholders whose names appear on the register of
members of the company at the close of business on 21 May 2015.